Language selection

Search

2004-03-18 - Male - 9 Years old

167150

Adverse reaction report number 167150
Latest AER version number 0
Market authorization holder AER number SUS1200300549
Initial received date 2004-03-18
Latest received date 2004-03-18
Age 9 Years
Gender Male
Weight 30 Kilograms
Type of report Special Access Program
Reporter type Physician
Source of report MAH
Report outcome Unknown
Serious report? Yes

Reason for seriousness

Death
Disability
Cogenital anomaly
Life threateting
Hospitalization
Other medically important Yes

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ADDERALL XRCAPSULE, EXTENDED RELEASESuspectOral10 Milligram1 every 1 Day(s)4 Day(s)

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Agitation
Self-injurious ideation
Date modified: